VANDA PHARMACEUTICALS INC (VNDA) Stock Earnings & Estimates
NASDAQ:VNDA - US9216591084 - Common Stock
4.67 USD
+0.06 (+1.3%)
4.67 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 254.4M -5.32% | 192.64M -24.28% | 198.772M 3.18% | 229.48M 15.45% | 316.27M 37.82% | 412.34M 30.38% | 245.82M -40.38% | 215.22M -12.45% | 197.88M -8.06% | |
| EBITDA YoY % growth | 9M -86.13% | -10.942M -221.58% | -32.528M -197.28% | -38.046M -16.96% | 12.138M 131.90% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 6.3M -89.84% | -13.952M -321.46% | -40.66M -191.43% | -120.683M -196.81% | -36.708M 69.58% | -27.438M 25.25% | -25.5M 7.06% | -43.86M -72.00% | -64.26M -46.51% | |
| Operating Margin | 2.48% | -7.24% | -20.46% | -52.59% | -11.61% | -6.65% | -10.37% | -20.38% | -32.47% | |
| EPS YoY % growth | 0.12 -79.31% | 0.05 -58.33% | -0.32 -740.00% | -1.84 -475.88% | -1.06 42.25% | -0.25 76.52% | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 -326.89% | -0.30 -278.25% | -0.27 46.96% | -0.15 67.48% | -0.07 82.30% | 0.04 114.61% |
| Revenue Q2Q % growth | 60.518M 27.00% | 66.231M 24.53% | 70.244M 40.37% | 77.52M 47.40% | 85.51M 41.30% | 94.758M 43.07% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.067M -146.06% | -22.139M -115.38% | -22.437M 45.31% | -16.598M 56.89% | -10.592M 60.87% | -2.277M 89.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.46 -475.00% | -0.36 | -0.10 | -26.44% |
| Q1 2025 Q2Q % growth | -0.50 -614.29% | -0.61 | 0.11 | 17.84% |
| Q4 2024 Q2Q % growth | -0.08 -100.00% | -0.11 | 0.03 | 26.47% |
| Q3 2024 Q2Q % growth | -0.09 | -0.17 | 0.08 | 45.98% |
| Q2 2024 Q2Q % growth | -0.08 -366.67% | -0.21 | 0.13 | 62.65% |
| Q1 2024 Q2Q % growth | -0.07 -216.67% | 0.05 | -0.12 | -237.25% |
| Q4 2023 Q2Q % growth | -0.04 -133.33% | -0.09 | 0.05 | 56.43% |
| Q3 2023 Q2Q % growth | 0.00 -100.00% | -0.04 | 0.04 | 100.00% |
| Q2 2023 Q2Q % growth | 0.03 -40.00% | -0.13 | 0.16 | 122.62% |
| Q1 2023 Q2Q % growth | 0.06 154.55% | % | ||
| Q4 2022 Q2Q % growth | 0.12 | 0.08 | 0.04 | 47.06% |
| Q3 2022 Q2Q % growth | 0.06 -57.14% | 0.09 | -0.03 | -34.64% |
| Q2 2022 Q2Q % growth | 0.05 -70.59% | 0.14 | -0.09 | -64.99% |
| Q1 2022 Q2Q % growth | -0.11 -173.33% | -0.01 | -0.10 | -978.43% |
| Q4 2021 Q2Q % growth | 0.12 -20.00% | 0.09 | 0.03 | 38.41% |
| Q3 2021 Q2Q % growth | 0.14 27.27% | 0.18 | -0.04 | -23.75% |
| Q2 2021 Q2Q % growth | 0.17 6.25% | 0.14 | 0.03 | 19.05% |
| Q1 2021 Q2Q % growth | 0.15 1,400.00% | 0.15 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | 0.15 87.50% | 0.14 | 0.01 | 8.13% |
| Q3 2020 Q2Q % growth | 0.11 -50.00% | 0.10 | 0.01 | 13.13% |
| Q2 2020 Q2Q % growth | 0.16 -23.81% | 0.04 | 0.12 | 259.20% |
| Q1 2020 Q2Q % growth | 0.01 200.00% | 0.00 | 0.01 | 460.22% |
| Q4 2019 Q2Q % growth | 0.08 | 0.12 | -0.04 | -30.59% |
| Q3 2019 Q2Q % growth | 0.22 | 0.07 | 0.15 | 196.48% |
| Q2 2019 Q2Q % growth | 0.21 | 0.00 | 0.21 | 4,579.14% |
| Q1 2019 Q2Q % growth | -0.01 | 0.07 | -0.08 | -115.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 52.59M 4.19% | 55.689M | -3.099M | -5.56% |
| Q1 2025 Q2Q % growth | 50.041M 5.44% | 46.037M | 4.004M | 8.70% |
| Q4 2024 Q2Q % growth | 53.185M 17.48% | 53.293M | -108K | -0.20% |
| Q3 2024 Q2Q % growth | 47.651M 22.76% | 50.138M | -2.487M | -4.96% |
| Q2 2024 Q2Q % growth | 50.474M 9.59% | 48.817M | 1.657M | 3.39% |
| Q1 2024 Q2Q % growth | 47.46M -24.06% | 49.47M | -2.01M | -4.06% |
| Q4 2023 Q2Q % growth | 45.271M -29.79% | 37.74M | 7.531M | 19.95% |
| Q3 2023 Q2Q % growth | 38.815M -40.58% | 45.39M | -6.575M | -14.49% |
| Q2 2023 Q2Q % growth | 46.056M -28.47% | 49.98M | -3.924M | -7.85% |
| Q1 2023 Q2Q % growth | 62.5M 3.84% | % | ||
| Q4 2022 Q2Q % growth | 64.48M -5.20% | 68.952M | -4.472M | -6.49% |
| Q3 2022 Q2Q % growth | 65.32M -6.82% | 72.42M | -7.1M | -9.80% |
| Q2 2022 Q2Q % growth | 64.39M -5.17% | 68.34M | -3.95M | -5.78% |
| Q1 2022 Q2Q % growth | 60.19M -3.96% | 59.16M | 1.03M | 1.74% |
| Q4 2021 Q2Q % growth | 68.02M 0.55% | 71.441M | -3.421M | -4.79% |
| Q3 2021 Q2Q % growth | 70.1M 16.23% | 75.735M | -5.635M | -7.44% |
| Q2 2021 Q2Q % growth | 67.9M 9.15% | 71.145M | -3.245M | -4.56% |
| Q1 2021 Q2Q % growth | 62.67M 8.05% | 69.87M | -7.2M | -10.30% |
| Q4 2020 Q2Q % growth | 67.65M 11.03% | 65.28M | 2.37M | 3.63% |
| Q3 2020 Q2Q % growth | 60.31M 1.38% | 65.229M | -4.919M | -7.54% |
| Q2 2020 Q2Q % growth | 62.21M 5.33% | 63.189M | -979K | -1.55% |
| Q1 2020 Q2Q % growth | 58M 21.57% | 58.004M | -4K | -0.01% |
| Q4 2019 Q2Q % growth | 60.93M | 60.767M | 163K | 0.27% |
| Q3 2019 Q2Q % growth | 59.49M | 59.492M | -2K | 0.00% |
| Q2 2019 Q2Q % growth | 59.06M | 55.229M | 3.831M | 6.94% |
| Q1 2019 Q2Q % growth | 47.71M | 52.775M | -5.065M | -9.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -11.88% | -126% | -20.98% | -20.98% |
| Revenue | 1.14% | -0.54% | -1.21% | -1.21% |